Target Hospitality(TH)
Search documents
Target Hospitality (TH) Beats Q4 Earnings and Revenue Estimates
ZACKS· 2025-03-26 12:55
Core Viewpoint - Target Hospitality reported quarterly earnings of $0.12 per share, exceeding the Zacks Consensus Estimate of $0.06 per share, but down from $0.29 per share a year ago, indicating a 100% earnings surprise [1] Financial Performance - The company achieved revenues of $83.69 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 4.48%, but down from $126.22 million year-over-year [2] - Over the last four quarters, Target Hospitality has consistently surpassed consensus EPS and revenue estimates [2] Stock Performance - Target Hospitality shares have declined approximately 36.6% since the beginning of the year, contrasting with the S&P 500's decline of 1.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.02 on revenues of $75.37 million, and for the current fiscal year, it is -$0.12 on revenues of $242.65 million [7] - The trend of earnings estimate revisions is mixed, which could change following the recent earnings report [6] Industry Context - The Leisure and Recreation Services industry, to which Target Hospitality belongs, is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]
Target Hospitality(TH) - 2024 Q4 - Annual Results
2025-03-26 10:53
Financial Performance - Revenue for the year ended December 31, 2024, was $386.3 million, a decrease of 31.4% compared to $563.6 million in 2023[6] - Net income for the year ended December 31, 2024, was $71.4 million, down 58.8% from $173.7 million in 2023[7] - Adjusted EBITDA for the year ended December 31, 2024, was $196.7 million, a decline of 42.9% from $344.2 million in 2023[7] - For Q4 2024, revenue was $83.7 million, down 33.6% from $126.2 million in Q4 2023[9] - Q4 2024 net income was $12.5 million, a decrease of 66.9% compared to $37.8 million in Q4 2023[10] - Total revenue for Q4 2024 was $83.688 million, a decrease of 33.7% compared to $126.220 million in Q4 2023[48] - Services income decreased to $60.227 million in Q4 2024 from $84.730 million in Q4 2023, representing a decline of 29.0%[48] - Specialty rental income fell to $23.461 million in Q4 2024, down 43.5% from $41.490 million in Q4 2023[48] - Gross profit for Q4 2024 was $37.031 million, a decrease of 40.5% compared to $62.239 million in Q4 2023[48] - Target Hospitality's total operating income for the year ended December 31, 2024, was $108.781 million, down from $240.606 million in 2023, indicating a significant decline in profitability[48] - Gross profit for the year 2024 was $178,179 thousand, compared to $313,324 thousand in 2023, indicating a decrease of 43.1%[54] Liquidity and Capital Structure - The company achieved approximately $366 million of total available liquidity and a net leverage ratio of 0.0x as of December 31, 2024[6] - The company executed approximately $33.4 million of stock repurchases during the year ended December 31, 2024[6] - The company reported a loss on extinguishment of debt of $2.279 million for the year ended December 31, 2024[48] - Total liabilities decreased to $304,684 thousand in 2024 from $317,046 thousand in 2023, a reduction of approximately 3.9%[50] - Total stockholders' equity attributable to Target Hospitality increased to $421,081 thousand in 2024 from $377,307 thousand in 2023, an increase of 11.6%[50] Cash Flow and Assets - Cash and cash equivalents rose significantly to $190,668 thousand in 2024, up from $103,929 thousand in 2023, marking an increase of 83.3%[52] - The company reported a net cash provided by operating activities of $151,675 thousand for 2024, slightly down from $156,801 thousand in 2023[52] - Discretionary cash flows for 2024 were $130,928 thousand, down from $142,583 thousand in 2023, reflecting a decline of 8.2%[56] - The company purchased specialty rental assets totaling $29,557 thousand in 2024, a decrease from $60,808 thousand in 2023[52] Future Outlook - The revised 2025 outlook projects total revenue between $265 million and $285 million, with adjusted EBITDA between $47 million and $57 million[23] - Adjusted EBITDA outlook for 2024 is expected to be a minimum of $100 million, reflecting management's confidence in operational performance despite current challenges[37] Contracts and Agreements - Target announced a multi-year Workforce Hub Contract expected to generate approximately $140 million of revenue through 2027[6] - A 5-year $246 million Dilley Contract was awarded, effective March 5, 2025, supporting U.S. government initiatives[6] Shareholder Information - The weighted average number of shares outstanding for Q4 2024 was 99,189,824, compared to 101,660,601 in Q4 2023[48]
Target Hospitality Reports Strong 2024 Results with Continued Focus on Advancing Strategic Diversification and Growth Opportunities
Prnewswire· 2025-03-26 10:45
Core Insights - Target Hospitality reported a significant decline in financial performance for the year ended December 31, 2024, with revenue of $386.3 million, down from $563.6 million in 2023, and net income of $71.4 million compared to $173.7 million in the previous year [5][6][12] - The company emphasized its operational flexibility and strategic growth initiatives, which have been crucial in navigating various business cycles and customer demand changes [3][4] - Target Hospitality secured a multi-year Workforce Hub Contract expected to generate approximately $140 million in revenue through 2027, indicating a focus on diversifying its contract portfolio [12][18] Financial and Operational Highlights - Full-year revenue for 2024 was $386.3 million, a decrease of 31.4% from $563.6 million in 2023 [5] - Net income for 2024 was $71.4 million, down 58.8% from $173.7 million in 2023 [6] - Adjusted EBITDA for 2024 was $196.7 million, a decline of 42.9% from $344.2 million in 2023 [6] - Average utilized beds decreased to 13,362 in 2024 from 14,463 in 2023, with utilization rates dropping to 83% from 90% [5] Fourth Quarter Summary - Revenue for Q4 2024 was $83.7 million, down 33.6% from $126.2 million in Q4 2023 [8] - Net income for Q4 2024 was $12.5 million, a decrease of 66.9% from $37.8 million in Q4 2023 [9] - Adjusted EBITDA for Q4 2024 was $41.1 million, down 39.2% from $67.7 million in Q4 2023 [9] Capital Management - The company achieved approximately $366 million in total available liquidity and maintained a net leverage ratio of 0.0x with zero net debt as of December 31, 2024 [12][13] - Target Hospitality executed approximately $33.4 million in stock repurchases during 2024, representing about 33.4% of the total share repurchase authorization [15] - On March 25, 2025, the company redeemed all outstanding 10.75% Senior Secured Notes due 2025, which is expected to save approximately $19.5 million in annual interest expenses [14] Business Update and Outlook - The company is positioned for growth with strong underlying business fundamentals and an efficient operating structure [16] - The recently announced Dilley Contract, valued at $246 million over five years, highlights the importance of Target's strategically located assets in supporting U.S. government initiatives [19] - Target's revised outlook for 2025 reflects the impact of the PCC contract termination and the new Dilley Contract, indicating a focus on government end-market growth opportunities [21]
Theratechnologies Receives FDA Approval for EGRIFTA WR™ (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and Lipodystrophy
Globenewswire· 2025-03-25 21:45
Core Viewpoint - Theratechnologies Inc. has received FDA approval for the new formulation of tesamorelin, named EGRIFTA WR™, which is set to replace the existing EGRIFTA SV formulation, offering improved convenience and patient experience [2][3][5]. Company Overview - Theratechnologies is a commercial-stage biopharmaceutical company focused on innovative therapies, with its stock listed on TSX and NASDAQ [10]. Product Details - EGRIFTA WR™ is the only FDA-approved medication for reducing excess abdominal fat in adults with HIV-related lipodystrophy [3]. - The new formulation requires less than half the administration volume compared to the previous EGRIFTA SV, which necessitated daily reconstitution [3]. - EGRIFTA WR™ is supplied in four single-patient-use vials, each containing 11.6 mg of tesamorelin, sufficient for seven doses, with a daily dose of 1.28 mg [4]. - The product can be stored at room temperature before and after reconstitution [4]. Clinical Significance - Central adiposity is a common complication for people with HIV, and the new formulation aims to address this issue effectively [5]. - The new formulation is expected to enhance patient compliance and experience in managing comorbidities associated with HIV [4][5]. Manufacturing and Patent Information - EGRIFTA WR™ will be manufactured at a new U.S.-based contract drug manufacturing organization (CDMO) [5]. - The formulation is patent protected in the U.S. until 2033 [5].
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
Globenewswire· 2025-03-12 11:30
Core Insights - Ibalizumab shows long-term efficacy and safety in reducing HIV RNA to undetectable levels in heavily treatment-experienced patients with multidrug-resistant HIV [1][2][6] - The PROMISE-US study indicates that patients on ibalizumab-containing regimens achieve similar rates of undetectable viral loads compared to those on non-ibalizumab regimens, despite having more severe HIV disease at baseline [2][4] Study Details - The PROMISE-US study is a phase 4, multicenter, observational registry study designed to assess the efficacy and durability of ibalizumab in combination with other antiretroviral therapies [3][6] - The interim analysis included 112 participants, with 70 in the non-ibalizumab cohort and 42 in the ibalizumab cohort, showing baseline viremia rates of 39% and 57% respectively [4] Treatment Outcomes - Among participants with baseline viremia, 50% of those in the non-ibalizumab cohort and 47% in the ibalizumab cohort achieved undetectable viral loads after six months [5] - At 12 months, 53% of the non-ibalizumab cohort and 42% of the ibalizumab cohort had undetectable viral loads [5] Safety Profile - Ibalizumab was well-tolerated, with no infusion reactions reported and no treatment discontinuations due to adverse events in the ibalizumab cohort [5]
Target Hospitality Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Schedule
Prnewswire· 2025-03-12 10:45
Core Points - Target Hospitality Corp. will release its fourth quarter and full year 2024 financial results on March 26, 2025, before the market opens [1] - A conference call to discuss the results is scheduled for the same day at 9:00 AM Eastern Time [1][3] - The conference call will be accessible via live webcast on the company's website [2] Company Overview - Target Hospitality is one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services [5] - The company builds, owns, and operates a customized network of communities, offering a full suite of services including food service management, concierge, laundry, logistics, security, and recreational facilities [5]
Arrow Bidco, LLC Announces Redemption of Senior Secured Notes Due 2025
Prnewswire· 2025-03-10 17:45
Core Viewpoint - Target Hospitality Corp. announced the redemption of all $181.4 million of its 10.75% senior secured notes due 2025, scheduled for March 25, 2025, at a redemption price of 101.000% of the principal amount plus accrued interest [1][2]. Company Overview - Target Hospitality is one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, offering a range of solutions including food service management, concierge, laundry, logistics, security, and recreational facilities services [5].
Target Hospitality Announces 5-year Contract Award Reactivating South Texas Assets
Prnewswire· 2025-03-06 11:45
Core Viewpoint - Target Hospitality Corp has entered into a five-year lease and services agreement with CoreCivic to reactivate operations at the Dilley Facility in Texas, which will support up to 2,400 individuals and is expected to generate over $246 million in revenue over its term [1][4][3] Company Overview - Target Hospitality is one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, offering a range of solutions including food service management, concierge, laundry, logistics, security, and recreational facilities [8] Contract Details - The Dilley Contract will maintain a similar economic structure to the previous agreement with CoreCivic, including fixed minimum revenue regardless of occupancy, with an anticipated revenue of approximately $30 million in 2025 [4][6] - The Dilley Facility previously operated from September 2014 to August 2024 as the South Texas Family Residential Center, and its reactivation will require no capital investment due to the consistency of the community layout [2][3] Strategic Importance - The reactivation of the Dilley Facility highlights Target's flexible operating model and unique capabilities, positioning the company to respond effectively to customer demand and pursue additional growth opportunities aligned with U.S. government immigration policies [5][6] - The Dilley Contract is supported by an amended intergovernmental services agreement with U.S. Immigration and Customs Enforcement, subject to annual appropriations and potential cancellation with 60 days' notice [7]
Earnings Preview: Target Hospitality (TH) Q4 Earnings Expected to Decline
ZACKS· 2025-03-05 16:00
Company Overview - Target Hospitality (TH) is expected to report a year-over-year decline in earnings, with a projected EPS of $0.07, reflecting a decrease of 75.9% compared to the previous year [3] - Revenues are anticipated to be $80.1 million, down 36.5% from the same quarter last year [3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised down by 80.77% over the last 30 days, indicating a significant reassessment by analysts [4] - The Most Accurate Estimate for Target Hospitality is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -25%, suggesting a bearish outlook from analysts [10][11] Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive or negative reading can predict the likelihood of an earnings beat or miss, with a strong predictor being a positive Earnings ESP combined with a favorable Zacks Rank [8][9] - Target Hospitality currently holds a Zacks Rank of 3 (Hold), making it challenging to predict an earnings beat [11] Historical Performance - In the last reported quarter, Target Hospitality exceeded the consensus EPS estimate of $0.12 by delivering earnings of $0.20, resulting in a surprise of +66.67% [12] - Over the past four quarters, the company has successfully beaten consensus EPS estimates on all occasions [13] Industry Comparison - Vail Resorts (MTN), a peer in the Zacks Leisure and Recreation Services industry, is expected to report an EPS of $6.29, reflecting a year-over-year increase of 9.2% [17] - Vail Resorts' revenues are projected to be $1.14 billion, up 5.6% from the previous year, with an Earnings ESP of 1.64% indicating a likelihood of beating the consensus EPS estimate [18]
Target Hospitality (TH) Loses -41.46% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-02-26 15:36
Core Viewpoint - Target Hospitality (TH) has experienced significant selling pressure, resulting in a 41.5% decline in stock price over the past four weeks, but analysts anticipate better earnings than previously expected, indicating potential for recovery [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is utilized to identify oversold stocks, with a reading below 30 typically indicating oversold conditions [2]. - TH's current RSI reading is 21.07, suggesting that the heavy selling may be exhausting itself and a trend reversal could be imminent [5]. Group 2: Fundamental Indicators - There is a consensus among sell-side analysts that earnings estimates for TH have increased by 1.9% over the last 30 days, which often correlates with price appreciation [6]. - TH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, further supporting the potential for a turnaround [7].